Cometriq
9 Topics Found
Cabozantinib S Malate
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib in its capsule formulation was approved by the U.S. Food and Drug Administration (FDA) under the name Cometriq for treating ...
Hello, I need to be able to get Cometriq for a cousin with Medullary Thyroid Cancer in Argentina. The only problem is that I need it from a licensed pharmacy that will accept a prescription from an Argentinian doctor. Please let me know what my best options are. Thanks ## We needed Cometriq (Cabozatinib) for my brother in Russia. We used an Israeli pharmacy. They accepted a Russian prescription and had a costumer service representative who spoke Russian. I'm sure that they can ship to Argentina as well. Good luck. ## @Diego, I don't think you'd run into any problems based on information from the previous comment. However, it sounds like your best bet would probably be to speak with a local pharmacist in your area who may know about certain information or laws relating to fil...
2 REPLIES
Filed under
Cometriq
Lung cancer treated by cometriq ## Anyone out there living on cometriq? I am stage four lung cancer patient in remission with continued use of cometriq. ## Hello, Allison! How are you? I'm very glad that it is working for you. Have you experienced many side effects, such as nausea, dizziness or mouth pain?
2 REPLIES
Filed under
Cometriq
Cabozantinib (S)-Malate
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib in its capsule formulation was approved by the U.S. Food and Drug Administration (FDA) under the name Cometriq for treating ...
Drug Index
Cabozantinib, sold under the brand names Cometriq and Cabometyx among others, is a medication used to treat medullary thyroid cancer, renal cell carcinoma, and hepatocellular carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. It was discovered and developed by Exelixis Inc. In November 2012, cabozantinib in its capsule formulation was approved by the U.S. Food and Drug Administration (FDA) under the name Cometriq for treating ...
NDC Database
Cometriq 100 mg Daily Dose Carton Pack, 4 Blister Cards, 14 Capsules Each by Exelixis, Inc. ## Markings: XL184;20mg XL184;80mg ## Shape: Capsule ## Package Codes: 42388-012-14 ## Active Ingredients: Cabozantinib
NDC Database
Cometriq 20 mg Oral Capsule by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-014-25 ## Active Ingredients: Cabozantinib S-malate
NDC Database
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) / 7 (Cabozantinib 80 mg Oral Capsule [cometriq]) } Pack [cometriq 140 mg Daily Dose Carton] by Exelixis, Inc. ## Markings: XL184;20mg XL184;80mg ## Shape: Capsule ## Package Codes: 42388-011-14 ## Active Ingredients: Cabozantinib
NDC Database
4 {21 (Cabozantinib 20 mg Oral Capsule [cometriq]) } Pack [cometriq 60 mg Daily Dose Carton] by Exelixis, Inc. ## Markings: XL184;20mg ## Shape: Capsule ## Color: Gray ## Package Codes: 42388-013-14 ## Active Ingredients: Cabozantinib S-malate